Drug · DIN 02488000
ARIPIPRAZOLE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 9, 2019; first marketed July 9, 2019.
- Drug Identification Number (DIN)
- 02488000
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Aripiprazole N05AX12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ARIPIPRAZOLE | 2 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 1, 2019: NOC 22114Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named ARIPIPRAZOLE
- DIN 02488019 · Marketed
- DIN 02488027 · Marketed
- DIN 02488035 · Marketed
- DIN 02488043 · Marketed
- DIN 02488051 · Marketed
- DIN 02506688 · Marketed
- DIN 02506718 · Marketed
- DIN 02506726 · Marketed
- DIN 02506734 · Marketed
- DIN 02506750 · Marketed
- DIN 02506785 · Marketed
- DIN 02534320 · Marketed
- DIN 02534339 · Marketed
- DIN 02534347 · Marketed
- DIN 02534355 · Marketed
- DIN 02534363 · Marketed
- DIN 02534371 · Marketed